Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Combination MMRV Vaccine Associated with Two-Fold Risk of Febrile Seizures Compared with Separate MMR & Varicella Vaccines

June 27, 2010 10:35 pm | by Bio-Medicine.Org | News | Comments

OAKLAND, Calif. , June 28 /- The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and...

TOPICS:

Global Pharmaceutical R & D Productivity Declining According to Thomson Reuters, CMR International

June 27, 2010 10:35 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA and LONDON , June 28 /- The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, whilst the proportion of total sales from newer drugs has dropped, according to data released today from the 2010 Pharmaceutical R&D Factbook complied...

TOPICS:

Researchers develop accurate way to predict the age when women will hit the menopause

June 27, 2010 8:40 pm | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) Researchers have developed a way of accurately predicting when women will hit the menopause using a simple blood test. The average difference between the predicted age and the actual age that the women in their study reached...

TOPICS:
Advertisement

Healthier cafeteria food, more intense gym classes lower students' diabetes risk

June 27, 2010 8:40 pm | by EurekAlert | News | Comments

(University of California - Irvine) Healthier cafeteria choices, longer and more intense periods of physical activity and robust in-school education programs can lower rates of obesity and other risk factors for type 2 diabetes, according to a national study called HEALTHY.

TOPICS:

Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds

June 27, 2010 8:40 pm | by EurekAlert | News | Comments

(NIH/National Institute of Diabetes and Digestive and Kidney Diseases) An intervention in middle schools lowered the obesity rate in students at highest risk for type 2 diabetes, those who started out overweight or obese in sixth grade, an NIH-funded study has found. However,...

TOPICS:

Building a Substitute Pancreas for Diabetics

June 27, 2010 8:38 pm | by Massachusetts Institute of Technology | News | Comments

A startup hopes implanted insulin-producing cells will free diabetics from insulin injections.

TOPICS:

Statins associated with lower cancer recurrence following prostatectomy

June 27, 2010 8:34 pm | by EurekAlert | News | Comments

(Duke University Medical Center) Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also...

TOPICS:

Why mercury is more dangerous in oceans

June 27, 2010 11:37 am | by EurekAlert | News | Comments

(Duke University) Even though freshwater concentrations of mercury are far greater than those found in seawater, it's the saltwater fish like tuna, mackerel and shark that end up posing a more serious health threat to humans who eat them.

TOPICS:
Advertisement

Gestational diabetes linked to serotonin and dietary protein

June 27, 2010 11:37 am | by EurekAlert | News | Comments

(University of California - San Francisco) The cause of diabetes during pregnancy is directly controlled by serotonin, a chemical produced by the body and normally known as a neurotransmitter, and is influenced by the amount of protein in the mother's diet early in pregnancy,...

TOPICS:

Carbon nanotubes form ultrasensitive biosensor to detect proteins

June 27, 2010 11:34 am | by EurekAlert | News | Comments

(Boston College) Boston College researchers have used carbon nanotubes and molecular imprinting to develop a biosensor capable of detecting proteins, according to a report in the journal Nature Nanotechnology.

TOPICS:

TGen-led studies identify genetic links to kidney disease, kidney failure

June 26, 2010 9:38 am | by EurekAlert | News | Comments

(The Translational Genomics Research Institute) Researchers at the Translational Genomics Research Institute will make two presentations at this week's 70th Scientific Sessions of the American Diabetes Association, June 25-29, in Orlando, Fla.

TOPICS:

New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and Metformin in Drug-Naive Adult Type 2 Diabetes Patients

June 26, 2010 9:37 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. , June 26 /- Results of a new study demonstrated that initial combination therapy with Welchol® (colesevelam HCl) 3.75 g/d and metformin (initiated at 850 mg/d; uptitrated to 1700 mg/d thereafter) significantly improved glycemic and lipid control in drug-naive adult...

TOPICS:

Improvement in Beta-Cell Function Observed After Three Years of BYETTA(R) Therapy: Data Presented at ADA 2010

June 26, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26, 2010 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY ) today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on...

TOPICS:

New Data Demonstrates Victoza® (liraglutide rDNA injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52...

June 26, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26 /- Poster 16LB -- Late-breaking Novo Nordisk (NVO) extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily Victoza® in combination with metformin produced sustained and...

TOPICS:

Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes

June 26, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 26 /- Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c (HbA1c),(1-4) fasting plasma glucose (FPG)(1-4) and postprandial glucose...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading